In head and neck squamous cell carcinoma (HNSCC), GM-CSF expression together with vascular endothelial growth factor (VEGF) and platelet-derived growth factor AB (PDGF-AB) correlated with significantly poorer patient prognosis 14. This evidence concerns the gene CSF2 and head and neck squamous cell carcinoma.